Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (158) Arrow Down
Filter Results: (158) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (158)
    • News  (56)
    • Research  (98)
    • Events  (1)
    • Multimedia  (1)
  • Faculty Publications  (61)

Show Results For

  • All HBS Web  (158)
    • News  (56)
    • Research  (98)
    • Events  (1)
    • Multimedia  (1)
  • Faculty Publications  (61)
← Page 6 of 158 Results →
  • 16 Sep 2016
  • News

Gaining Ground on ALS

Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical View Details
  • 01 Jun 2018
  • News

Floor It

case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
  • Fast Answer

Pharmaceuticals: Pipeline

where can I find pharmaceuticals pipeline data? In addition to the following sources, we suggest that you also check company’s website for latest pipeline info. You may begin with: Bloomberg - It is Drug Profiles allows to screen by... View Details
  • 13 Oct 2016
  • News

Adding Muscle to the Fight Against Disease

20 years to get where we are,” shares Blum, “but the tradeoff is that today we have several very promising therapies that are in late-stage trials.” One of those therapies is tirasemtiv, the drug in the Phase 3 View Details
Keywords: Deborah Blagg
  • 24 Sep 2020
  • News

The Race for a Vaccine

Pisano says. But vaccines don’t really fit the same business model as high-volume therapeutic drugs; they have an even higher bar for safety and effectiveness, because unlike most other drugs they are administered to healthy populations.... View Details
Keywords: April White; COVID-19; Scientific Research and Development Services
  • 15 Dec 2024
  • News

After Ozempic

Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details
Keywords: Jen McFarland Flint; Illustrations by Pete Ryan; Ambulatory Health Care Services; Health, Social Assistance
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

the preferred testing ground for Phase 1 clinical trials of new drugs, the benefits of massive R&D spending and economic throw-offs are being enjoyed elsewhere, primarily in the United States and in an increasingly competitive Asia.... View Details
Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
  • 20 Aug 2014
  • News

With No Time to Lose

an effective biomarker—a kind of test that could measure the progression of ALS over a short period of time—did not yet exist. Without it, drug trials relied on longer, more costly observations of disease... View Details
Keywords: Margie Kelley
  • 01 Jun 2003
  • News

Ruling from the Bench

notorious criminals. Presiding over complex, multidefendant trials at the height of the 1980s crack cocaine epidemic, Snyder stared down members of the “Wild Cowboys” drug gang like Daniel (“Fat Danny”)... View Details
Keywords: Julia Hanna; Justice, Public Order, and Safety Activities; Government
  • Web

Kraft Accelerator

Podcast Podcast Showcasing the business models, technologies, and proof points of data & analytics leaders in precision medicine. Subscribe on Apple Podcasts More Ways to Listen Google Play Stitcher Spotify 25 Sep 2019 Under the Datascope Make Me a Match! How AI Can... View Details
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

the anatomical—basis of the disease." Genzyme, which currently has drugs in clinical trials for melanoma and breast cancer, hopes to have its first products on the market as early as 2004. "I think... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • 15 Jan 2018
  • Research & Ideas

A Better Business Model for Fighting Cancer

benefits of sharing data, which can then be used to more quickly identify the most pressing targets and design trials to address them. Innovations to the typical clinical trial model are also being used. In... View Details
Keywords: by Julia Hanna; Health; Pharmaceutical
  • 01 Dec 2013
  • News

Your Own Medicine

says. "That's just unheard of." If all goes well, the next move could be trials for FDA approval. And HT-100 is just one of the drugs that DART is involved in. It is funding a cardiac View Details
Keywords: Morrell, Daniel; biomedicine; biopharmaceutical company; Ambulatory Health Care Services; Health, Social Assistance
  • 01 Mar 2016
  • News

Off Script

(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high... View Details
Keywords: Insurance Carriers and Related Activities; Finance
  • 10 Oct 2017
  • First Look

First Look at New Research and Ideas, October 10, 2017

Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new cancer View Details
Keywords: Sean Silverthorne
  • 01 Dec 2019
  • News

The Race Against Resistance

people die as a result. And yet, there are only 42 antibiotics currently in clinical development, and typically only 20 percent of infectious disease drugs that enter phase 1 clinical trials will receive FDA... View Details
Keywords: Lisa Scanlon Mogolov
  • 01 Jun 2000
  • News

The Business of Biotech

currently has drugs in clinical trials for mela-noma and breast cancer, hopes to have its first products on the market as early as 2004. "I think we're going to see more people in the next decade who are... View Details
Keywords: Julia Hanna
  • 04 Sep 2019
  • News

Accelerating Scientific Discovery

reduce human disease and suffering influences his work as a health care economist and researcher. “I imagine a world where we have treatments, ideally cures, for diseases where right now we have nothing,” he says. “So the big questions that motivate me are, what are... View Details
Keywords: Jennifer Gillespie
  • 26 Jun 2000
  • Research & Ideas

What’s an Internet Business Model? Ask a Health Care Professional

out how to get into a clinical trial to try an experimental drug. For their part, physicians are often befuddled by difficult cases that don't respond to traditional therapies. And pharmaceutical companies, at the same time, are anxious... View Details
Keywords: by Martha Lagace; Health
  • Web

Student Spotlight: From Nigeria to HBS: Reigniting My Passion for Healthcare Innovation - Blog: Health Supplement

Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS Insurance/payor Medical... View Details
  • ←
  • 6
  • 7
  • 8
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.